You have 9 free searches left this month | for more free features.

CRS-207

Showing 1 - 25 of 398

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Pancreatic Adenocarcinoma Trial in Baltimore (Epacadostat, Pembrolizumab, CRS-207)

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 3, 2023

Pancreatic Cancer Trial in Baltimore (Tadalafil, Pembrolizumab, Ipilimumab)

Recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Aug 23, 2022

Previously Treated Metastatic Adenocarcinoma of the Pancreas Trial in United States (CRS-207, nivolumab, GVAX)

Completed
  • Previously Treated Metastatic Adenocarcinoma of the Pancreas
  • CRS-207
  • +3 more
  • San Francisco, California
  • +4 more
Mar 17, 2021

Tuberculosis, HIV Trial in United States (Efavirenz (EFV), TMC207)

Completed
  • Tuberculosis
  • HIV
  • San Francisco, California
  • +4 more
Oct 28, 2021

Malignant Pleural Mesothelioma Trial in United States (Immunotherapy plus chemo, Immunotherapy with cyclophosphamide plus chemo)

Completed
  • Malignant Pleural Mesothelioma
  • Immunotherapy plus chemotherapy
  • Immunotherapy with cyclophosphamide plus chemotherapy
  • San Francisco, California
  • +4 more
Sep 28, 2020

Platinum-resistant Ovarian Cancer, Platinum-resistant Fallopian Cancer, Platinum-resistant Peritoneal Cancer Trial in Canada,

Terminated
  • Platinum-resistant Ovarian Cancer
  • +2 more
  • CRS-207
  • +2 more
  • Scottsdale, Arizona
  • +11 more
Apr 1, 2019

Pancreatic Cancer Trial in Baltimore (Tislelizumab, SX-682)

Not yet recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    Johns Hopkins SKCCC
Jan 23, 2023

Asthma, Chronic Rhinosinusitis With Nasal Polyps, Chronic Rhinosinusitis (Diagnosis) Trial in Wien (procedure, diagnostic test,

Recruiting
  • Asthma
  • +3 more
  • Blood sampling
  • +12 more
  • Wien, Austria
    Allgemeines Krankenhaus (AKH) Wien
Nov 10, 2021

Multiple Myeloma, Smoldering Multiple Myeloma Trial in Boston (Ciltacabtagene Autoleucel, Cyclophosphamide, Fludarabine

Not yet recruiting
  • Multiple Myeloma
  • Smoldering Multiple Myeloma
  • Ciltacabtagene Autoleucel
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 2, 2023

EGFR Mutant Advanced NSCLC Trial (BBT-207)

Not yet recruiting
  • EGFR Mutant Advanced Non-Small Cell Lung Cancer
  • (no location specified)
Jun 16, 2023

Relapsed/Refractory T-cell Acute Lymphoid Leukaemia Trial in London (Cryopreserved BE CAR7 T cells (BE752TBCCLCAR7PBL))

Recruiting
  • Relapsed/Refractory T-cell Acute Lymphoid Leukaemia
  • Cryopreserved BE CAR7 T cells (BE752TBCCLCAR7PBL)
  • London, United Kingdom
    Ilyas Ali
May 25, 2022

The Women's HIV SeroIncidence Study (ISIS)

Completed
  • HIV Infections
    • Washington, District of Columbia
    • +8 more
    Aug 25, 2022

    HIV Trial in Puerto Rico, Tanzania, United States (Zidovudine, Zalcitabine, Didanosine)

    Completed
    • HIV Infections
    • Los Angeles, California
    • +36 more
    Oct 28, 2021

    Cytoreductive Surgery, Hyperthermic Intraperitoneal Chemo, Hydration Trial in Beijing (Urine-guided hydration, Routine

    Not yet recruiting
    • Cytoreductive Surgery
    • +5 more
    • Urine-guided hydration
    • +3 more
    • Beijing, China
      Aerospace Center Hospital
    Jul 11, 2023

    Consciousness Disorders Trial in Hangzhou (Facial expression; Electroencephalogram; MRI)

    Recruiting
    • Consciousness Disorders
    • Facial expression; Electroencephalogram; MRI
    • Hangzhou, Zhejiang, China
      First Affiliated Hospital,Zhejiang University
    Oct 12, 2023

    Severe Neutropenia After HIPEC Using Mitomycin-C

    Recruiting
    • Colorectal Cancer Metastatic
    • +3 more
    • Intraoperative blood and peritoneal fluid samplings during HIPEC
    • Seoul, Korea, Republic of
      Division of Colon and Rectal Surgery, Department of Surgery, Gan
    Aug 21, 2022

    Propel Drug-Eluting Sinus Stent Family

    Recruiting
    • Chronic Rhinosinusitis (Diagnosis)
    • NA-Observational Registry
    • Wiesbaden, Germany
      Helios Dr Horst Schmidt Kliniken
    Jun 19, 2023

    Multiple Myeloma Trial in Worldwide (BL-8040 1.25mg/kg + G-CSF, Placebo +G-CSF)

    Active, not recruiting
    • Multiple Myeloma
    • BL-8040 1.25mg/kg + G-CSF
    • Placebo +G-CSF
    • Los Angeles, California
    • +17 more
    Jun 14, 2022

    Chronic Rhinosinusitis With Nasal Polyps Trial in Vancouver (Mepolizumab)

    Not yet recruiting
    • Chronic Rhinosinusitis With Nasal Polyps
    • Vancouver, British Columbia, Canada
      St. Paul's Sinus Centre
    Oct 24, 2023

    Sinusitis, Chronic, Sinus Disease, Sinus Infection Trial in Vancouver (Sinonasal Microbiota Transfer, Sham Sinonasal Microbiota

    Recruiting
    • Sinusitis, Chronic
    • +3 more
    • Sinonasal Microbiota Transfer
    • Sham Sinonasal Microbiota Transfer
    • Vancouver, British Columbia, Canada
      St. Paul's Hospital
    Jul 15, 2022

    Chronic Rhinosinusitis (Diagnosis) Trial in Brisbane, Melbourne (Microbiome Transplant, Placebo)

    Recruiting
    • Chronic Rhinosinusitis (Diagnosis)
    • Microbiome Transplant
    • Placebo
    • Brisbane, Queensland, Australia
    • +2 more
    Nov 10, 2022

    Ovarian Cancer, Drug Related Tumor/Cancer Trial (secondary cytoreductive surgery, chemo)

    Not yet recruiting
    • Ovarian Cancer
    • Drug Related Neoplasm/Cancer
    • (no location specified)
    Jan 28, 2023

    Peritoneal Carcinomatosis, Peritoneal Mesothelioma, Ovarian Cancer Trial run by the NCI (Mitomycin C, Cisplatin, Heated

    Recruiting
    • Peritoneal Carcinomatosis
    • +4 more
    • Mitomycin C
    • +6 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 28, 2023

    Hyperuricemia Trial in BeiJing (Placebo, fasted vs. high-fat meal)

    Recruiting
    • Hyperuricemia
    • Placebo
    • fasted vs. high-fat meal
    • BeiJing, Beijing, China
      Peking university Third Hospital
    Dec 20, 2021

    B-Cell Non-Hodgkin Lymphoma Trial in Seattle (Anakinra)

    Recruiting
    • B-Cell Non-Hodgkin Lymphoma
    • Anakinra
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 11, 2023